Lindane 1% for scabies

References

Citations

1. Drugs for parasitic infections (August 2004). Medical Letter on Drugs and Therapeutics. Available online: http://www.medicalletter.org.

2. Centers for Disease Control and Prevention (2006). Sexually transmitted diseases treatment guidelines, 2006. MMWR, 55(RR-11): 79–80.

3. U.S. Food and Drug Administration (2003). FDA issues health advisory regarding labeling changes for lindane products. FDA Talk Paper T03-19. Available online: http://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01205.html.

4. Stone SP (2003). Scabies and pediculosis. In IM Freedberg et al., eds., Fitzpatrick's Dermatology in General Medicine, 6th ed., vol. 2, chap. 238, pp. 2283–2289. New York: McGraw-Hill.

Author:	Shannon Erstad, MBA/MPH	Last Updated: April 4, 2007
Medical Review:	Adam Husney, MD - Family Medicine Kathleen Romito, MD - Family Medicine
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.